According to the ACR-2011 classification of treatment groups, the polyarthritis group, oligoarthritis group, psoriatic group, the systemic group with active arthritis, and the systemic group with active system disease accounted for 44.6%, 28.4%, 18.4%, 6.8%, and 1.4%, respectively.